Literature DB >> 24758849

[Complications of endoscopic nasal and sinus surgery: experience in 150 patients].

Alejandro Martín Vargas-Aguayo1, Rosalba Elizabeth Copado-Ceballos, Eulalio Vivar-Acevedo, Salomón Waizel-Haiat, Roxana Contreras-Herrera, Eduardo Desentis-Vargas.   

Abstract

BACKGROUND: Endoscopic nasal and sinus surgery has been used greatly for the treatment of inflammatory and neoplasm pathology, as well as for the approach of the extrasinus structures. Although it has proven to be a very successful method, it is not exempt of complications. Our objective was to identify the frequency of complications in patients with sinus and nasal pathology that underwent an endoscopic surgery of the nose and sinuses.
METHODS: A total of 150 patients who underwent endoscopic sinus surgery, 75 women and 75 men, in a specialties hospital of the Instituto Mexicano del Seguro Social (IMSS). The type of pathology, surgical technique done, major and minor adverse event presented were recorded.
RESULTS: We observed an overall complication rate of 18 %: 2.7 % corresponded to major, and 15.3 % to minor. The main pathologies were chronic rhinosinusitis without polyps (24.7 %) and sinus nasal tumors (22 %).
CONCLUSIONS: The overall complications and the major rates were similar to those reported in the literature. On the other hand, the minor adverse events were slightly higher. Still, endoscopic surgery has become a safe surgical treatment option.

Entities:  

Keywords:  Endoscopy; Nose; Paranasal sinuses; Postoperative complications

Mesh:

Year:  2014        PMID: 24758849

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  1 in total

1.  Anatomical variations of the ethmoidal roof: differences between men and women.

Authors:  Milton Alberto Muñoz-Leija; Masao Yamamoto-Ramos; Francisco Jesús Barrera-Flores; José Luis Treviño-González; Alejandro Quiroga-Garza; Marco Antonio Méndez-Sáenz; Mario Alberto Campos-Coy; Guillermo Elizondo-Rojas; Santos Guzmán-López; Rodrigo Enrique Elizondo-Omaña
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-09       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.